Li Lijuan, Wu Jian, Sima Xiutian, Bai Peng, Deng Wei, Deng Xueke, Zhang Lin, Gao Linbo
Department of Forensic Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China.
Tumour Biol. 2013 Jun;34(3):1919-23. doi: 10.1007/s13277-013-0736-9. Epub 2013 Mar 17.
Growing evidence indicates that tumor suppressor gene TP-53 and non-coding RNA miR-34b/c independently and/or jointly play crucial roles in carcinogenesis. We hypothesized that the polymorphisms of rs4938723 in the promoter region of pri-miR-34b/c and TP-53 Arg72-Pro may be related to the risk of nasopharyngeal carcinoma (NPC). We performed a case-control study between 217 patients with NPC and 360 healthy controls in a Chinese population using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. A significantly increased risk of NPC was observed in the miR-34b/c rs4938723 CT/CC genotypes compared with the TT genotype (adjusted OR=1.44, 95 % CI 1.02-2.03, p=0.04), and also the C allele (adjusted OR=1.33, 95 % CI 1.04-1.70, p=0.03). The gene-gene interaction of miR-34b/c rs4938723 and TP-53 Arg72-Pro showed that the combined genotypes of rs4938723CT/CC and TP-53CG/CC increased the risk of NPC (rs4938723CT/CC + TP-53CG/CC vs. rs4938723 TT+TP-53 CG/CC: OR=1.58, 95 % CI 1.04-2.42, p=0.03). These findings suggest that miR-34b/c rs4938723 and TP-53 Arg72Pro polymorphisms may singly or collaboratively contribute to the risk of NPC.
Genet Test Mol Biomarkers. 2015-4
Clin Dev Immunol. 2012
Genet Test Mol Biomarkers. 2016-7
Dis Markers. 2019-9-10
Front Oncol. 2018-9-26
J Biomed Res. 2018-9-6
Int J Mol Epidemiol Genet. 2017-2-15
Clin Dev Immunol. 2012
Sci Signal. 2011-11-1
World J Gastroenterol. 2011-9-14
Oncol Rep. 2011-3-3
Cancer Genet Cytogenet. 2010-3